Clinical Trial Update: Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT [Phase 3]

View source ↗

Summary

Phase 3 trial comparing eltrombopag to rhTPO for increasing platelets after hematopoietic stem cell transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation-related Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Shenzhen Second People's Hospital | Conditions: Eltrombopag, Hematopoietic Stem Cell Transplantation | Phase 3 | Status: COMPLETED